1-6 of 6
Vinciane Rebours
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors

Subject Area:
Endocrinology , Neurology and Neuroscience
Louis de Mestier, Anne-Laure Védie, Matthieu Faron, Jérôme Cros, Vinciane Rebours, Olivia Hentic, Christine Do Cao, Pascal Bardet, Philippe Lévy, Alain Sauvanet, Philippe Ruszniewski, Pascal Hammel
Journal: Neuroendocrinology
Neuroendocrinology (2020) 110 (11-12): 967–976.
https://doi.org/10.1159/000505158
Published Online: 03 December 2019
View article titled, The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors
Open the PDF for The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors in another window
Journal Articles

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Subject Area:
Endocrinology , Neurology and Neuroscience
Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard-Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski
Journal: Neuroendocrinology
Neuroendocrinology (2020) 110 (1-2): 83–91.
https://doi.org/10.1159/000500862
Published Online: 10 May 2019
View article titled, Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Open the PDF for Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor in another window
Journal Articles

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Subject Area:
Endocrinology , Neurology and Neuroscience
Louis de Mestier, Thomas Walter, Hedia Brixi, Camille Evrard, Jean-Louis Legoux, Paul de Boissieu, Olivia Hentic, Jérôme Cros, Pascal Hammel, David Tougeron, Catherine Lombard-Bohas, Vinciane Rebours, Philippe Ruszniewski, Guillaume Cadiot
Journal: Neuroendocrinology
Neuroendocrinology (2019) 108 (4): 343–353.
https://doi.org/10.1159/000498887
Published Online: 13 February 2019
View article titled, Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Open the PDF for Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses in another window
Journal Articles

18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation

Subject Area:
Endocrinology , Neurology and Neuroscience
Margot Bucau, Astrid Laurent-Bellue, Nicolas Poté, Olivia Hentic, Jérôme Cros, Nidaa Mikail, Vinciane Rebours, Philippe Ruszniewski, Rachida Lebtahi, Anne Couvelard
Journal: Neuroendocrinology
Neuroendocrinology (2018) 106 (3): 274–282.
https://doi.org/10.1159/000480239
Published Online: 11 August 2017
View article titled, 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation
Open the PDF for 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation in another window
Journal Articles

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

Subject Area:
Endocrinology , Neurology and Neuroscience
Frédérique Maire, Catherine Lombard-Bohas, Dermot O’Toole, Marie-Pierre Vullierme, Vinciane Rebours, Anne Couvelard, Anne Laure Pelletier, Magaly Zappa, Frank Pilleul, Olivia Hentic, Pascal Hammel, Philippe Ruszniewski
Journal: Neuroendocrinology
Neuroendocrinology (2012) 96 (4): 294–300.
https://doi.org/10.1159/000336941
Published Online: 11 April 2012
View article titled, Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study
Open the PDF for Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study in another window
Journal Articles

The Expression of the Hypoxia Markers CA9 and CXCR4 Is Correlated with Survival in Patients with Neuroendocrine Tumours of the Ileum

Subject Area:
Endocrinology , Neurology and Neuroscience
Lydia Deschamps, Dhouha Bacha, Vinciane Rebours, Mouniya Mebarki, Frédéric Bretagnol, Yves Panis, Pierre Bedossa, Philippe Ruszniewski, Anne Couvelard
Journal: Neuroendocrinology
Neuroendocrinology (2012) 95 (3): 214–222.
https://doi.org/10.1159/000329873
Published Online: 29 November 2011
View article titled, The Expression of the Hypoxia Markers CA9 and CXCR4 Is Correlated with Survival in Patients with Neuroendocrine Tumours of the Ileum
Open the PDF for The Expression of the Hypoxia Markers CA9 and CXCR4 Is Correlated with Survival in Patients with Neuroendocrine Tumours of the Ileum in another window